Anti-MBP (Maltose Binding Protein) mAb (Monoclonal Antibody)
MBP Monoclonal Antibody.


Specifications:
Description
Monoclonal Antibody of 100 μg targeting maltose binding protein for IPP, WB.
Target: | MBP |
---|---|
Product Type: | Antibody |
Size: | 100 μg |
Application: | IP, WB |
Research Area / Disease: | Epitope Tag |
Conjugate: | Unlabeled |
Antibody Type: | Monoclonal |
Clone Number: | 1G12 |
Concentration: | 1 mg/mL |
Formulation: | 100 μg IgG in 100 μl of PBS containing 50% glycerol, pH 7.2. Contains no preservatives. |
Isotype: | IgG3 |
Immunogen: | pMAL-C2G/JM109 |
Host Species: | Mouse |
Source: | This antibody was purified from hybridoma(clone 1G12) supernatant using protein A agarose. Thishybridoma was established by fusion of mouse myelomacell P3-U1 with Balb/c mouse lymphocyte immunizedwith pMALC2-G/JM109. |
Reactivity: | This antibody reacts with MBP onWestern blotting. |
Gene ID Human: | |
Gene ID Mouse: | |
Storage Temperature: | -20°C |
Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
Citations
- Ito T et al. Alteration of substrate specificity: the variable N-terminal domain of tobacco Ca(2+)-dependent protein kinase is important for substrate recognition. Plant Cell 22, 1592-604 (2010),
- Kasahara K et al. Ubiquitin-proteasome system controls ciliogenesis at the initial step of axoneme extension. Nat Commun. 5, 5081 (2014)
- Shu T et al. Ebola virus VP35 has novel NTPase and helicase-like activities. Nucleic Acids Res. 47, 5837-5851 (2019)